Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and preliminary antitumor activity of U3-1402: A HER3-targeted antibody drug conjugate in EGFR TKI-resistant, EGFRm NSCLC
    Meeting Abstract

    Janne, P. A.; Yu, H. A.; Johnson, M. L.; Steuer, C. E.; Vigliotti, M.; Iacobucci, C.; Chen, S.; Yu, C.; Sellami, D. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions
    Meeting Abstract

    Janne, P. A.; Neal, J. W.; Camidge, D. R.; Spira, A. I.; Piotrowska, Z.; Horn, L.; Costa, D. B.; Tsao, A. S.; Patel, J. D.; Gadgeel, S. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ia/b study of TIM-3/PD-L1 bispecific antibody in patients with advanced solid tumors
    Meeting Abstract

    Hellmann, M. D.; Shimizu, T.; Doi, T.; Hodi, F. S.; Rottey, S.; Aftimos, P. G.; Liu, Z. T.; de Mendizabal, N. V.; Szpurka, A. M.; Piao, Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in adult TRK fusion cancer patients
    Meeting Abstract

    Hong, D. S.; Kummar, S.; Farago, A. F.; Lassen, U. N.; Berlin, J.; Schilder, R. J.; McDermott, R. S.; Patel, J. D.; Dowlati, A.; Doebele, R. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular circulating tumor DNA response to identify long-term survival in patients receiving immunotherapy with initial radiologic stable disease
    Meeting Abstract

    Hellmann, M. D.; Zhang, Q.; Abdullah, S. E.; Chaft, J. E.; Segal, N. H.; Gao, C.; Dennis, P. A.; Higgs, B. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor volumetric correlation with plasma cell free DNA (cfDNA) mutation detection in metastatic lung cancers
    Meeting Abstract

    Haseltine, J.; Offin, M.; Myers, M. L.; Makhnin, A.; Adamski, A.; Li, H.; Li, M.; Shaffer, T.; Henderson, S.; Shen, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MET inhibitor resistance in patients with MET exon 14-altered lung cancers
    Meeting Abstract

    Guo, R.; Offin, M.; Brannon, A. R.; Chow, A.; Delasos, L.; Somwar, R.; Wilkins, O.; Scott, K.; Tian, Y.; Cecchi, F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Biomarker-directed precision oncology of pembrolizumab-based combination therapy for non small cell lung cancer: Phase II KEYNOTE-495/KeyImPaCT study
    Meeting Abstract

    Gutierrez, M.; Hellmann, M. D.; Gubens, M. A.; Aggarwal, C.; Tan, D. S. W.; Felip, E.; Chiu, J. W. Y.; Lee, J. S.; Yang, J. C. H.; Garon, E. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors
    Meeting Abstract

    Drilon, A. E.; DuBois, S. G.; Farago, A. F.; Geoerger, B.; Grilley-Olson, J. E.; Hong, D. S.; Sohal, D.; van Tilburg, C. M.; Ziegler, D. S.; Ku, N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • NRG1 fusion-positive lung cancers: Clinicopathologic profile and treatment outcomes from a global multicenter registry
    Meeting Abstract

    Duruisseaux, M.; Liu, S. V.; Han, J. Y.; Gounant, V.; Shih, J. Y.; Schram, A. M.; Schrock, A. B.; Ali, S. M.; Magne, F.; Monnet, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save